Company performance
Add to research
Current Price
as of Jun 18, 2025$1.81
P/E Ratio
N/A
Market Cap
$53.52M
Description
Add to research
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.
Metrics
Add to research
Overview
- HQBay Harbor Islands, FL
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerFBIO
- Price$1.81-1.09%
Trading Information
- Market cap$53.52M
- Float71.45%
- Average Daily Volume (1m)229,443
- Average Daily Volume (3m)212,151
- EPS-$2.32
Company
- Revenue$57.78M
- Rev growth (1yr)0.84%
- Net income-$10.58M
- Gross margin54.48%
- EBITDA margin-157.10%
- EBITDA-$20.64M
- EV$34.40M
- EV/Revenue0.60
- P/EN/A
- P/S0.83
- P/B2.40
- Debt/Equity333.64
Documents
Add to research
SEC Filings
Factset Street Account